ZUPERON Trademark

Trademark Overview


On Tuesday, November 6, 2012, a trademark application was filed for ZUPERON with the United States Patent and Trademark Office. The USPTO has given the ZUPERON trademark a serial number of 85772800. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 18, 2016. This trademark is owned by Glaxo Group Limited. The ZUPERON trademark is filed in the Pharmaceutical Products category with the following description:

(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, meta...
zuperon

General Information


Serial Number85772800
Word MarkZUPERON
Filing DateTuesday, November 6, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 18, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 16, 2013

Trademark Statements


Goods and Services(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 13, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Monday, July 18, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 18, 2016ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 1, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 30, 2015EXTENSION 5 GRANTED
Thursday, November 19, 2015EXTENSION 5 FILED
Thursday, November 19, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 5, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 4, 2015EXTENSION 4 GRANTED
Monday, June 1, 2015EXTENSION 4 FILED
Monday, June 1, 2015TEAS EXTENSION RECEIVED
Wednesday, December 3, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 2, 2014EXTENSION 3 GRANTED
Thursday, November 20, 2014EXTENSION 3 FILED
Thursday, November 20, 2014TEAS EXTENSION RECEIVED
Thursday, June 12, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 11, 2014EXTENSION 2 GRANTED
Thursday, May 22, 2014EXTENSION 2 FILED
Tuesday, June 10, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 22, 2014TEAS EXTENSION RECEIVED
Wednesday, December 4, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 2, 2013EXTENSION 1 GRANTED
Monday, December 2, 2013EXTENSION 1 FILED
Monday, December 2, 2013TEAS EXTENSION RECEIVED
Tuesday, June 11, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 16, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 16, 2013PUBLISHED FOR OPPOSITION
Wednesday, March 27, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 5, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 4, 2013ASSIGNED TO EXAMINER
Tuesday, November 13, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 9, 2012NEW APPLICATION ENTERED IN TRAM